Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.66 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28105328 | 0.98 | CYP4F2 (0.63) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL29104226 | 0.95 | CYP4F2 (0.60) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL30608259 | 0.91 | CYP4F2 (0.53) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL5557393 | 0.87 | CYP4F2 (0.72) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL444076 | 0.85 | CYP4F2 (0.63) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL18050498 | 0.85 | CYP4F2 (0.50) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL17617119 | 0.84 | CYP4F2 (0.48) | CYP4F2CYP4A11MEN1KMT2AATM | |
| SCHEMBL28231496 | 0.84 | CYP4F2 (0.63) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL25247450 | 0.84 | CYP4F2 (0.73) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL9574956 | 0.84 | CYP4F2 (0.73) | CYP4F2CYP4A11MEN1KMT2APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | API CORPORATION (JP) | 2016-03-24 | — | — | US | disclosed |
| CN-1040874-C | Triazolopyridazine compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-11-25 | — | — | CN | disclosed |
| US-5461140-A | Bioerodible polymers for solid controlled release pharmaceutical compositions | PHARMACEUTICAL DELIVERY SYSTEMS (US) | 1995-10-24 | — | — | US | disclosed |
| CN-1077958-A | The preparation of triazolopyridazine compounds, their and purposes | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1993-11-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | MGMT, GSTA1, CBS | CYP4F2 104/4885CYP4A11 298/4885MEN1 3023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.